Yong Man Kim
Net worth: 1 703 $ as of 2026-05-30
Net worth: 1 703 $ as of 2026-05-30
Yong Man Kim is currently Chief Scientific Officer & Director at NKMAX Co., Ltd. since 2021 and Chief Scientific Officer at NKGen Biotech, Inc. since 2023.
Former positions include Director, Chief Scientific & Innovation Officer at NKGen Operating Biotech, Inc. from 2021 to 2023 and Research Professor at Wonkwang University.
Education includes a doctorate from Chungnam National University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.02% | 2025-10-06 | 28,384 ( 0.02% ) | 1 703 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies finished pharmaceutical products | Chief Tech/Sci/R&D Officer | 2017-08-31 |
| Companies | Position | End |
|---|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Chief Tech/Sci/R&D Officer | 2023-08-31 |
Wonkwang University
Wonkwang University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Wonkwang University
Wonkwang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chungnam National University
Chungnam National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies finished pharmaceutical products | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions